ARTICLE

FindCenter AddIcon

COVID-19 Q&A: Dr. Lawrence Fung on Impacts on the Neurodiverse Community

By Lawrence Fung

As scientists learn more about the novel Coronavirus, the consensus is that even with more effective treatments and possible vaccines, COVID-19 will likely be with us for a long time to come. New ways of working and learning will continue to evolve, and the many varieties of talents and skills will need to be accommodated for full inclusion. That includes the neurodiverse community. For this insight we turn to Dr. Lawrence Fung, Director of the Stanford Neurodiversity Project (SNP), and the Adult Neurodevelopment Clinic, as well as Assistant Professor of Psychiatry and Behavioral Sciences.

Read on med.stanford.edu

FindCenter Post-Image

Ketamine Therapy Is Going Mainstream. Are We Ready?

The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.

FindCenter AddIcon
FindCenter Post-Image

One Dose of ‘Magic Mushroom’ Drug Reduces Anxiety and Depression in Cancer Patients, Study Says

A single dose of psilocybin, a compound found in “magic mushrooms,” provides long-term relief of anxiety and depression in cancer patients, a new study finds.

FindCenter AddIcon
FindCenter Post-Image

Single Dose of Psychedelic Drug Eased Cancer Patients’ Anxiety, Depression for Years

The new research looked at cancer patients who took part in a study nearly five years ago.

FindCenter AddIcon
FindCenter Post-Image

Are Psychedelics the Answer to Depression and Addiction?

A new generation of research into psilocybin could change how we treat numerous mental health conditions.

FindCenter AddIcon

EXPLORE TOPIC

Neurodiversity